On Monday, the companies said in a joint statement that India's Cipla (CIPL.NS) has signed a deal with Eli Lilly (LLY.N) to sell and distribute two of the U.S. drugmaker's best-selling diabetes treatments in the country. The companies said, Lilly will transfer its rights in India to sell, promote
On Wednesday, the U.S. House Judiciary Committee voted to approve three bills to restrain practices drugmakers use to raise prices and fend off competition, including a bill to ban the tactic of paying generic companies to delay bringing cheaper versions of their medicines to market. Committee